| Tag | Content |
|---|
EnhancerAtlas ID | HS054-00649 |
Organism | Homo sapiens |
Tissue/cell | FT246 |
Coordinate | chr1:208107760-208109460 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr1:208108491-208108512 | AAAGAGGAAGTAAAAGTTAAA | - | 6.1 | | IRF1 | MA0050.2 | chr1:208108485-208108506 | AAAAAGAAAGAGGAAGTAAAA | - | 7.1 | | SPI1 | MA0080.4 | chr1:208108489-208108503 | AGAAAGAGGAAGTA | + | 6.87 | | SPIC | MA0687.1 | chr1:208108489-208108503 | AGAAAGAGGAAGTA | + | 7.52 | | TCF7L2 | MA0523.1 | chr1:208108302-208108316 | TCTCTTTGATCTGT | - | 6.04 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_13353 | chr1:208107812-208108490 | CD34_Primary_RO01536 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH01I207934 | chr1 | 208107813 | 208108490 | | GH01I207935 | chr1 | 208108581 | 208108730 |
|
Enhancer Sequence | AGAATTCTTC TGCCTCAGCC TCCTGAGAAG CTGGGACTAC AGGTGTGCAC CACTGCGCCT 60
GGCTAATTTT TGCATTTTTG GTAGAGACAG GGTCTCACCA TGTTGGCCAG ACTGGTCTCA 120
AACTCCTGGC CTCAGGTGAT CCACCCACCT CAGCCTCCCA GAGTGCTGGG ATTACAGGCG 180
TGAGCCACCA CACCTGGCCA GTTTTCTAGT ATTTTGTCTT GAATTCTGTA TCTCTGCTTA 240
TTAATGGGTT GATATGTGAT TTTTCTTTCT TACTGTCCTA GTATGCTTTT GCTTTAAAGT 300
TCTATTAGCC TGGTAAAATA AGTGGTTAGT ATTTCTTCTT TGTCTATTAT CTGGAAGTAT 360
TTATATAAAT TGGAATTACT TGTTCCTTGA CTGTTTTACA GAACTCACCA CTAAAATGTC 420
TGAGTCTTGG GTGAGAATGT ATCTGTGTGG GTAAATTTTT ATCCTTATTC AACTTATTTA 480
ATAATTATAG CAACATGCAG ATTTTCTATT TATTTTTTAG TCAGTTTTGA TGTGTAATAT 540
TTTCTCTTTG ATCTGTTTTC AAACTTTAAA GTACATAATT GTTCATACTA GTCTCGGTAT 600
TTAAAACTAT CTTGTATATC TACAGTTATG AGTTATTTTC AAATTCCAAT ATTTATTATT 660
TTCCTTCTTT CTTTTTTAAA AAAATTAAGG AAGGAGGCCA CCTCTCTTAT TGTCTCATAC 720
CTCAGAAAAA GAAAGAGGAA GTAAAAGTTA AAGAAAGGCA AAAATGAGAT CAATAAACAG 780
CCCTGTGCTG CACCCCAGAC CTGGTCTAGT AGTTAAAAAT CAACCCCTGA CCTAACCACT 840
TGTATTATCT ATAGATTCCA GGCATTGTAT GAGAAAGCAC TGTGAAACTT TCTGTTCTGT 900
TCTGTCTTGA TTACTGATGC ATGCAGCCCC AGCCACGTAC CCCATGCTTG CTCAATCAAT 960
CATGACCCTT TCACATGGAC TCCCTTAGAG CTGTAAGCCC TTAAAAGGGG CAGGCATTTC 1020
TCTCTTGGGG AGCTCTGTTT TTTGGATGCA AGTCTGCTGA AGCTCCTGGC TGAATAAAGC 1080
CACTTCCTTC TTTAACCCAG TGTCTGAGGG GTTTTGTCCA CAGCTCATCC TCCTGCAAAA 1140
TCAATCTAGT TACAAAGTGT CAGTCTTTAA AATCTCAAAA CATCAACTTT TGGCTTTGTT 1200
CTCTTTGTGC ATTCTGTTGT TCTTTTTGCA ATTTCTTAAG ACATTTAACT CATTAATTTC 1260
CATTCTTATT TTCTAATATA AATATTTAAG TCTGCAAAAT CGCCACCAAT ATCTCCTTTT 1320
CTGTGTTACA CATAATTGGA TATGTAGTAT TTTACTACCA TTTAAGCTTA CGTTTTTTCC 1380
AATTTCCACC TTGATTTATT CTTCAGTACA TGGATTTTTT AGAAGCATTT TTAAATTTTC 1440
AAAAATCTTG GATTTGTTAT CTTTGTAAAG AAACCACTTA GCTCCATTTT GGTCAGAATA 1500
GATAGTGTCT ATGATATGAC AACTTTCCTA CTTACAGAGA CTTGTTTAAT AAACTAATAA 1560
TACATGTTGA TAAGTGTTCC TTTACTTGAG CAGATGTACA TTTGCCAGTT GGTAGTTTCA 1620
GAGTACTATA TACAGCTACT GGAATAAATA TTGATTATAT CACTTAAATC TACTGGTAGC 1680
TGATTGACTG CTTAATCTAT 1700
|
